These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38990642)

  • 21. Fabrication and optimization of febuxostat-loaded chitosan nanocarriers for better pharmacokinetics profile.
    Tayyab M; Haseeb MT; Alsahli TG; Khaliq NU; Hussain MA; Khan R; Nawaz A; Iqbal A; Alanazi AS; Bukhari SNA
    Int J Biol Macromol; 2024 Feb; 257(Pt 1):128448. PubMed ID: 38042323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stability, Intracellular Delivery, and Release of siRNA from Chitosan Nanoparticles Using Different Cross-Linkers.
    Raja MA; Katas H; Jing Wen T
    PLoS One; 2015; 10(6):e0128963. PubMed ID: 26068222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Free amino groups on the surface of chitosan nanoparticles and its characteristics].
    Lin AH; Liu YM; Ping QN
    Yao Xue Xue Bao; 2007 Mar; 42(3):323-8. PubMed ID: 17520835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Staggered Herringbone Microfluid Device for the Manufacturing of Chitosan/TPP Nanoparticles: Systematic Optimization and Preliminary Biological Evaluation.
    Chiesa E; Greco A; Riva F; Tosca EM; Dorati R; Pisani S; Modena T; Conti B; Genta I
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Edoxaban: a new oral direct factor xa inhibitor.
    Camm AJ; Bounameaux H
    Drugs; 2011 Aug; 71(12):1503-26. PubMed ID: 21861537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytotoxicity Enhancement of α-Mangostin with Folate-Conjugated Chitosan Nanoparticles in MCF-7 Breast Cancer Cells.
    Herdiana Y; Wathoni N; Shamsuddin S; Muchtaridi M
    Molecules; 2023 Nov; 28(22):. PubMed ID: 38005306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Response Surface Methodology for Statistical Optimization of Chitosan/Alginate Nanoparticles as a Vehicle for Recombinant Human Bone Morphogenetic Protein-2 Delivery.
    Zohri M; Akbari Javar H; Gazori T; Khoshayand MR; Aghaee-Bakhtiari SH; Ghahremani MH
    Int J Nanomedicine; 2020; 15():8345-8356. PubMed ID: 33154637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of a direct Factor Xa inhibitor, edoxaban, with dalteparin and ximelagatran: a randomised controlled trial in healthy elderly adults.
    Samama MM; Kunitada S; Oursin A; Depasse F; Heptinstall S
    Thromb Res; 2010 Oct; 126(4):e286-93. PubMed ID: 20807664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chitosan-tripolyphosphate nanoparticles: Optimization of formulation parameters for improving process yield at a novel pH using artificial neural networks.
    Hashad RA; Ishak RA; Fahmy S; Mansour S; Geneidi AS
    Int J Biol Macromol; 2016 May; 86():50-8. PubMed ID: 26783636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
    Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
    Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation, optimization, and in-vitro/in-vivo/ex-vivo characterization of chitosan-heparin nanoparticles: drug-induced gelation.
    Shahbazi MA; Hamidi M; Mohammadi-Samani S
    J Pharm Pharmacol; 2013 Aug; 65(8):1118-33. PubMed ID: 23837580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electrospray fabrication of doxorubicin-chitosan-tripolyphosphate nanoparticles for delivery of doxorubicin.
    Songsurang K; Praphairaksit N; Siraleartmukul K; Muangsin N
    Arch Pharm Res; 2011 Apr; 34(4):583-92. PubMed ID: 21544723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Edoxaban: a focused review of its clinical pharmacology.
    Lip GY; Agnelli G
    Eur Heart J; 2014 Jul; 35(28):1844-55. PubMed ID: 24810388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Edoxaban: Impact on routine and specific coagulation assays. A practical laboratory guide.
    Douxfils J; Chatelain B; Chatelain C; Dogné JM; Mullier F
    Thromb Haemost; 2016 Jan; 115(2):368-81. PubMed ID: 26510969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formulated chitosan-sodium tripolyphosphate nanoparticles for co-encapsulation of ellagic acid and anti-inflammatory peptide: characterization, stability and anti-inflammatory activity.
    Xiong Y; Feng YX; Chang M; Wang Q; Yin SN; Jian LY; Ren DF
    J Sci Food Agric; 2023 May; 103(7):3447-3456. PubMed ID: 36812130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Co-encapsulated resveratrol and quercetin in chitosan and peg modified chitosan nanoparticles: For efficient intra ocular pressure reduction.
    Natesan S; Pandian S; Ponnusamy C; Palanichamy R; Muthusamy S; Kandasamy R
    Int J Biol Macromol; 2017 Nov; 104(Pt B):1837-1845. PubMed ID: 28472691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting.
    Fazil M; Md S; Haque S; Kumar M; Baboota S; Sahni JK; Ali J
    Eur J Pharm Sci; 2012 Aug; 47(1):6-15. PubMed ID: 22561106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation and characterization of insulin chitosan-nanoparticles loaded in buccal films.
    Al-Nemrawi NK; Alsharif SSM; Alzoubi KH; Alkhatib RQ
    Pharm Dev Technol; 2019 Oct; 24(8):967-974. PubMed ID: 31092092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipid-based nano-formulation platform for eplerenone oral delivery as a potential treatment of chronic central serous chorioretinopathy:
    Abd-Elhakeem E; El-Nabarawi M; Shamma R
    Drug Deliv; 2021 Dec; 28(1):642-654. PubMed ID: 33787445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation, characterization and toxicology properties of α- and β-chitosan Maillard reaction products nanoparticles.
    Zhang H; Zhang Y; Bao E; Zhao Y
    Int J Biol Macromol; 2016 Aug; 89():287-96. PubMed ID: 27132881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.